Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease

Bor, Renáta, Farkas, Klaudia, Fábián, Anna, Bálint, Anita, Milassin, Ágnes, Rutka, Mariann, Matuz, Mária, Nagy, Ferenc, Szepes, Zoltán, Molnár, Tamás: Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease.
PLOS ONE, 12 (3). e0172916. ISSN 1932-6203 (2017)

[img]
Preview
Text
3220191_Bor_journal.pone.0172916_u.pdf - Published Version

Download (994kB) | Preview
Item Type: Article
Journal or Publication Title: PLOS ONE
Date: 2017
Volume: 12
Number: 3
Page Range: e0172916
ISSN: 1932-6203
Publisher: Public Library of Science (PLoS)
Faculty: Faculty of Pharmacy
Faculty of Medicine
Institution: Szegedi Tudományegyetem
SWORD language: angol
MTMT id: 3220191
DOI id: https://doi.org/10.1371/journal.pone.0172916
Date Deposited: 2017. May. 29. 16:12
Last Modified: 2017. May. 29. 16:12
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/11479
Web of Science® Times Cited: 3 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year